LACTB and infection: Meropenem/vaborbactam and imipenem + cilastatin and relebactam are newly introduced carbapenems combined with β-lactamase inhibitors to enhance efficacy against resistant bacteria and are increasingly used for the treatment of complex and resistant infections caused by beta-lactamase-producing bacteria.